The global neurothrombectomy devices market was valued at USD 739.80 Million in 2024, driven by the rising number of patients suffering from acute ischemic stroke and technological advancements in neurothrombectomy devices across the globe. The market is anticipated to grow at a CAGR of 7.20% during the forecast period of 2025-2034 to achieve a value of USD 1482.73 Million by 2034.
Base Year
Historical Period
Forecast Period
Rising stroke incidence and ageing populations are driving demand for neurothrombectomy devices, with healthcare systems increasingly adopting minimally invasive stroke treatments to improve patient outcomes and reduce long-term disabilities.
Technological advancements, including AI-assisted imaging and next-generation catheter designs, are enhancing procedure efficiency and success rates, attracting significant investments from medical device manufacturers, and expanding the neurothrombectomy devices market.
Favourable regulatory approvals and reimbursement policies in key markets, coupled with growing adoption in emerging economies, are accelerating market expansion, making neurothrombectomy devices more accessible for stroke treatment worldwide.
Compound Annual Growth Rate
7.2%
Value in USD Million
2025-2034
Neurothrombectomy Devices Market Outlook
*this image is indicative*
Neurothrombectomy devices are medical tools used to remove blood clots from cerebral arteries in patients experiencing acute ischemic stroke. These devices restore blood flow by mechanically retrieving or aspirating clots, reducing stroke-related disability. Key types include stent retrievers and aspiration catheters, often used alongside thrombolytic therapy. Advancements in catheter design, imaging technology, and minimally invasive techniques have improved success rates and patient outcomes. With increasing stroke cases globally, neurothrombectomy devices play a crucial role in emergency stroke care, offering faster clot removal and improved survival rates compared to traditional treatment methods.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Demand for Advanced Catheter Systems to Drive Market Growth
The market is expanding due to the increasing incidence of ischemic strokes and advancements in catheter-based interventions. Minimally invasive procedures are becoming the standard of care, boosting demand for high-precision neurovascular tools. For instance, in July 2024, Route 92 Medical, Inc. launched the FreeClimb® 88 catheter system, cleared by the FDA (510(k)), featuring improved flexibility and navigation through complex neurovasculature. This development is set to drive market growth by enhancing procedural success rates, reducing complications, and providing physicians with greater accessibility to challenging anatomical locations. As healthcare providers increasingly adopt innovative neurovascular technologies, demand for next-generation catheter systems will continue to fuel the market’s expansion during the forecast period.
Technological Advancements in Balloon Guide Catheters to Enhance Neurothrombectomy Devices Market Demand
The market is driven by the rising adoption of mechanical thrombectomy (MT) and continuous advancements in endovascular technologies. For instance, in September 2024, CERENOVUS, Inc. (Johnson & Johnson MedTech) introduced the EMBOGUARD Balloon Guide Catheter, designed to optimize clot removal during MT procedures. This device improves first-pass recanalization rates, reduces procedural time, and minimizes the risk of clot fragmentation, which can cause secondary ischemic events. The launch of next-generation balloon guide catheters is expected to accelerate market development by enhancing procedural efficiency, improving patient outcomes, and strengthening the adoption of MT in stroke treatment protocols. As demand for effective stroke management solutions rises, the market is poised for significant advancements and innovation.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Neurothrombectomy Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Stent Retrievers to Dominate the Segment by Product
Stent retrievers are poised to hold the largest market share due to their high efficacy in restoring blood flow in acute ischemic stroke patients. Their minimally invasive nature, rapid clot removal capabilities, and proven clinical outcomes drive adoption. Technological advancements in self-expanding designs enhance their efficiency, reducing procedure time and complications. Increasing stroke prevalence, rising emergency procedures, and growing awareness of mechanical thrombectomy further fuel demand. With healthcare facilities prioritising innovative stroke treatment solutions, stent retrievers will continue to dominate, supported by ongoing clinical trials, favourable regulatory approvals, and expanding indications for neurovascular interventions.
Acute Ischemic Stroke to Leading the Neurothrombectomy Devices Market Segmentation by Application
Acute ischemic stroke (AIS) is set to hold the largest market share, driven by its high global incidence and urgent need for rapid intervention. Neurothrombectomy devices play a critical role in reducing disability and mortality when used within the golden treatment window. As per the analysis by Expert Market Research, the ischemic stroke market is expected to grow at a CAGR of 5.2% during the forecast period of 2025-2034 . Increasing adoption of mechanical thrombectomy, advancements in stroke imaging, and rising healthcare investments support growth. Additionally, government initiatives promoting stroke awareness and treatment accessibility enhance market penetration. With a growing ageing population, rising risk factors like hypertension and diabetes, and expanding emergency care networks, the AIS segment is expected to drive substantial market expansion.
Hospitals to Lead the Neurothrombectomy Devices Market by End User
Hospitals are expected to dominate the market due to their advanced infrastructure, availability of neurointerventional specialists, and increasing stroke admissions. As primary centres for acute stroke treatment, hospitals benefit from favourable reimbursement policies, ongoing clinical trials, and access to cutting-edge thrombectomy technologies. The shift towards comprehensive stroke centres and the expansion of neurovascular units further strengthens hospital dominance. Increasing public and private healthcare investments, along with growing adoption of AI-assisted imaging and robotic-assisted thrombectomy, enhance treatment efficiency. With continuous advancements in stroke care protocols, hospitals will remain the leading segment, driving overall market growth and innovation.
Neurothrombectomy Devices Market Analysis by Region
North America is set to dominate the devices market, driven by high healthcare expenditure, advanced medical infrastructure, and increasing stroke prevalence. The region benefits from technological advancements, favourable reimbursement policies, and strong regulatory support for neurovascular devices. Rising awareness of early stroke intervention and an ageing population further fuel market growth. Additionally, key players are investing in R&D and expanding product portfolios, strengthening market penetration. With a growing focus on minimally invasive stroke treatment and increasing adoption of mechanical thrombectomy devices, North America remains the largest and fastest-growing regional market for neurothrombectomy devices.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in Dublin, Ireland, Medtronic plc was founded in 1949 and is a global leader in medical technology. The company’s neurothrombectomy portfolio includes Solitaire™ X Revascularisation Device, a widely used stent retriever for acute ischemic stroke treatment. Medtronic focuses on minimally invasive therapies, offering advanced stroke management solutions that enhance patient outcomes. With a strong presence in the North American market, Medtronic continues to innovate in neuroscience technologies, supporting early intervention and improved recanalisation rates for patients suffering from large vessel occlusions (LVOs).
Established in 1941 and headquartered in Kalamazoo, Michigan, USA, Stryker Corporation is a leading provider of medical devices and stroke care solutions. Its neurothrombectomy product line includes the Trevo® NXT ProVue Retriever, designed for rapid clot removal in ischemic stroke patients. The company specialises in neurovascular innovations, offering stent retrievers, aspiration catheters, and integrated stroke care technologies. In September 2024, Stryker acquired NICO Corporation, enhancing its neurotechnology portfolio with minimally invasive surgical solutions for intracerebral hemorrhage (ICH) and tumor procedures, strengthening stroke and neurovascular care. Stryker’s commitment to research and development drives continuous advancements in neurointervention, supporting improved revascularisation, procedural efficiency, and patient outcomes in the acute ischemic stroke treatment market.
Founded in 2004 and headquartered in Alameda, California, USA, Penumbra, Inc. is a key player in neurovascular intervention technologies. The company’s REAL™ Revascularisation System and Penumbra JET® aspiration catheters are widely used for mechanical thrombectomy in acute ischemic stroke. In June 2024, Penumbra launched BMX™81 and BMX™96 in Europe for neurovascular stroke management, expanding its advanced neuro access portfolio. Penumbra is known for its aspiration-based thrombectomy solutions, which aim to enhance clot removal efficiency while minimising complications. With a strong focus on continuous innovation and physician collaboration, Penumbra continues to advance minimally invasive stroke treatments, supporting improved clinical outcomes and patient recovery in the market.
A subsidiary of Johnson & Johnson, Cerenovus is headquartered in Irvine, California, USA, and focuses on neurovascular technologies. The company offers advanced neurothrombectomy solutions, including the EMBOTRAP® III Revascularisation Device and CEREBASE™ DA Guide Sheath, designed for efficient clot retrieval in ischemic stroke. With a commitment to stroke care innovation, Cerenovus integrates research-driven design, biomaterials expertise, and clinical insights to improve patient outcomes. Backed by Johnson & Johnson’s extensive healthcare network, Cerenovus continues to expand its neurovascular portfolio, providing cutting-edge thrombectomy devices for stroke treatment worldwide.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Boston Scientific Corporation, AngioDynamics, Inc., Terumo Corporation, Acandis GmbH, Phenox GmbH, and Vesalio, LLC.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
